Growth Metrics

Corcept Therapeutics (CORT) Change in Inventory (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Change in Inventory for 15 consecutive years, with $3.3 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Inventory rose 640.83% year-over-year to $3.3 million; the TTM value through Mar 2026 reached $11.4 million, up 15458.9%, while the annual FY2025 figure was $7.5 million, 2552.79% up from the prior year.
  • Change in Inventory hit $3.3 million in Q1 2026 for Corcept Therapeutics, up from -$483000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $4.6 million in Q2 2025 and bottomed at -$1.1 million in Q3 2024.
  • Average Change in Inventory over 5 years is $469647.1, with a median of -$329000.0 recorded in 2023.
  • Year-over-year, Change in Inventory plummeted 719.23% in 2025 and then soared 640.83% in 2026.
  • Corcept Therapeutics' Change in Inventory stood at -$125000.0 in 2022, then plummeted by 163.2% to -$329000.0 in 2023, then surged by 123.71% to $78000.0 in 2024, then crashed by 719.23% to -$483000.0 in 2025, then surged by 777.43% to $3.3 million in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $3.3 million, -$483000.0, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.